2.32

3.73% -0.09

Heron Therapeutics Inc (HRTX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HRTX Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$2.41

Aprire:

$2.4

Volume 24 ore:

1.03M

Relative Volume:

0.50

Capitalizzazione di mercato:

$353.40M

Reddito:

$137.74M

Utile/perdita netta:

$-27.97M

Rapporto P/E:

-14.50

EPS:

-0.16

Flusso di cassa netto:

$-9.61M

1 W Prestazione:

-1.69%

1M Prestazione:

+40.61%

6M Prestazione:

+24.06%

1 anno Prestazione:

-22.92%

Intervallo 1D:

$2.25

$2.42

Intervallo di 1 settimana:

$2.12

$2.45

Portata 52W:

$1.04

$3.93

Heron Therapeutics Inc Stock (HRTX) Company Profile

Nome

Heron Therapeutics Inc

Settore

Healthcare (1169)

Industria

Biotechnology (679)

Telefono

(858) 251-4400

Indirizzo

4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA

Dipendente

122

Cinguettio

Prossima data di guadagno

2024-11-12

Ultimi documenti SEC

HRTX's Discussions on Twitter

Confronta HRTX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HRTX Heron Therapeutics Inc	2.32	353.40M	137.74M	-27.97M	-9.61M	-0.16
VRTX Vertex Pharmaceuticals Inc	502.92	129.14B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	680.61	74.41B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	581.21	35.31B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	241.75	31.30B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	254.57	27.35B	3.32B	-860.46M	-1.04B	-8.32

Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-06-13	Iniziato	Rodman & Renshaw	Buy
2024-04-23	Iniziato	CapitalOne	Overweight
2024-03-13	Reiterato	Needham	Buy
2020-05-27	Iniziato	Guggenheim	Buy
2020-02-20	Reiterato	Needham	Buy
2019-01-16	Reiterato	Needham	Buy
2018-04-05	Iniziato	Evercore ISI	Outperform
2018-03-19	Reiterato	Mizuho	Buy
2018-03-01	Reiterato	Needham	Buy
2018-01-03	Iniziato	Leerink Partners	Outperform
2017-09-27	Iniziato	Northland Capital	Outperform
2017-02-27	Iniziato	Needham	Buy
2016-10-26	Iniziato	Aegis Capital	Buy
2016-09-06	Ripresa	Lake Street	Buy
2016-05-03	Iniziato	Cantor Fitzgerald	Buy
2015-12-10	Iniziato	Lake Street	Buy
2015-09-23	Reiterato	Leerink Partners	Outperform
2015-09-02	Iniziato	BofA/Merrill	Buy
2015-08-03	Reiterato	Brean Capital	Buy
2015-06-30	Reiterato	JMP Securities	Mkt Outperform
2015-06-19	Reiterato	Leerink Partners	Outperform
2014-08-07	Iniziato	Noble Financial	Buy

Mostra tutto

Heron Therapeutics Inc Borsa (HRTX) Ultime notizie

Mar 12, 2025

Heron Therapeutics (HRTX) Projected to Post Quarterly Earnings on Tuesday - MarketBeat

Mar 12, 2025

CM Management LLC Purchases 200,000 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Mar 12, 2025

Mar 11, 2025

StockNews.com Downgrades Heron Therapeutics (NASDAQ:HRTX) to Hold - MarketBeat

Mar 11, 2025

Why Heron Therapeutics Inc Stock Might Make Sense If Bought Today - Stocks Register

Mar 11, 2025

Mar 09, 2025

Los Angeles Capital Management LLC Sells 153,181 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Mar 09, 2025

Principal Financial Group Inc. Raises Stock Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Mar 09, 2025

Heron Therapeutics (HRTX) to Release Quarterly Earnings on Tuesday - Defense World

Mar 09, 2025

Mar 08, 2025

Heron Therapeutics: Four Horse Race Of Approved Therapies (NASDAQ:HRTX) - Seeking Alpha

Mar 08, 2025

Heron Therapeutics (NASDAQ:HRTX) Downgraded by StockNews.com to Hold - Defense World

Mar 08, 2025

Mar 07, 2025

Heron Therapeutics (NASDAQ:HRTX) Earns "Buy" Rating from Needham & Company LLC - MarketBeat

Mar 04, 2025

Heron Therapeutics (NASDAQ:HRTX) Posts Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat

Mar 04, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by D.A. Davidson & CO. - MarketBeat

Mar 04, 2025

Mar 03, 2025

Heron Therapeutics (NASDAQ:HRTX) Releases Quarterly Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat

Mar 03, 2025

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm - accessnewswire.com

Mar 03, 2025

Brokers Offer Predictions for HRTX Q1 Earnings - Defense World

Mar 03, 2025

Heron Therapeutics’ (HRTX) Buy Rating Reiterated at Needham & Company LLC - Defense World

Mar 03, 2025

Mar 02, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance

Mar 02, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Purchased by New York State Common Retirement Fund - Defense World

Mar 02, 2025

Heron Therapeutics (NASDAQ:HRTX) Stock Rating Upgraded by StockNews.com - Defense World

Mar 02, 2025

Mar 01, 2025

Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Shares Bounce 48% But Its Business Still Trails The Industry - Simply Wall St

Mar 01, 2025

Feb 28, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025

High Growth Tech Stocks to Watch in US Market February 2025 - Yahoo Finance

Feb 28, 2025

Heron Therapeutics (NASDAQ:HRTX) shareholders are up 19% this past week, but still in the red over the last five years - Simply Wall St

Feb 28, 2025